4
Changes in Ownership
EXELIXIS, INC. Filed Acc 0000939767-20-000160
EVP, Scientific Strategy & CSO sold 65,000 shares at $20.01 ($1,300,650)
- EVP, Scientific Strategy & CSO acquired 65,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lamb Peter · EVP, Scientific Strategy & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 1 in the form | +65,000 | $1.70 | $110,500 | 348,124 | D |
| 2020-12-18 | Sale : show line 2 in the form | −65,000 | $20.01 | $1,300,650 | 283,124 | D |
| Open-market sales · 65,000 sh · avg $20.01 · $1,300,650 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 3 in the form Option (right to buy) | −65,000 | $1.70 | 2021-09-18 | 65,000 | 255,000 | D |
Loading xslF345X03/wf-form4_160868509495790.xml…